The World Health Organization classifies processed meats as carcinogens and says red meat is probably a carcinogen. Our cancer nutritionists recommend eating only small amounts of red meat, and avoiding processed meats.
With all the focus on a plant-based diet for overall health and reduction of cancer risk, and recent media hype reporting red and processed meat cause cancer, meat lovers are left to wonder if their favorite foods are still allowed.
The WHO (World Health Organization’s) International Agency for Research on Cancer just released its analysis of the literature to date and concluded red meat and processed meat are likely carcinogenic, or cancer-causing foods. They cited a 17% – 18% increased risk of colorectal cancer with as little as two ounces of processed meat or four of ounces red meat per day. Continue reading →
mCancerPartner interviewed Dan Hayes, M.D., clinical director of the Cancer Center’s breast oncology program. In late September 2015, investigators – including Dr. Hayes – showed that many women with early stage breast cancer can skip chemotherapy with good results, based on a gene test assessing which tumors were more likely to respond to chemotherapy. This study validates clinical recommendations in place since 2007 made by the American Society of Clinical Oncology and the National Comprehensive Cancer Network. Dr. Hayes served on both recommendation task forces and provided the following remarks on the origin of these recommendations.
mCancerPartner: How has the standard of care for women with the most common type of breast cancer (early stage, hormone positive, HER2 negative, not spread to lymph nodes) evolved over the years? Continue reading →
Abnormal pancreas cells that have not yet turned into cancer
Editor’s note: This is part of a series of blogs that focus on members of the Pancreatic Cancer Research Center. Led by an inter-disciplinary team of scientists and clinicians, the Center holds the promise to significantly change the bleak statistics associated with this disease by revolutionizing pancreatic cancer care. One therapeutic tool they are advancing involves gathering pancreatic cancer cells from the bloodstream, assembling them into replicas of a patient’s tumor and testing various drug combinations on the copies to develop personalized medicine for each patient.
Pancreatic cancer patients are getting closer to the day when a small amount of their own blood will provide enough information so that doctors can recommend personalized treatments targeting the whole tumor. If you ask Diane Simeone, M.D., the Lazar J. Greenfield Professor of Surgery and director of the Pancreatic Cancer Center, this vision of the future may become reality in the next five years. Continue reading →
The FDA has approved Opdivo® (Nivolumab) and Keytruda® (Pembrolizumab) to treat patients with advanced non-small cell lung cancer. Both medicines stimulate a patient’s own immune system to destroy cancer cells.
Lung cancer is the leading cause of cancer death in the United States, with an estimated 224,210 new diagnoses in 2014. The most common type of lung cancer, non-small cell lung cancer or NSCLC, affects seven out of eight lung cancer patients.
In October 2015, the U.S. Food and Drug Administration approved Opdivo® (Nivolumab) and Keytruda® (Pembrolizumab) to treat patients with advanced, or metastatic, NSCLC. Both medicines stimulate a patient’s own immune system to destroy cancer cells.
Yellowing of the skin and eyes, along with weight loss, itchy skin and feeling tired are some of the symptoms of liver cancer.
As scary as these symptoms might be, many of the signs and symptoms of liver cancer can also be caused by other conditions, including other liver problems or even a vitamin overdose. None-the-less, yellowing of the skin and eyes, along with weight loss, itchy skin and feeling tired are some of the symptoms of liver cancer. By the time these symptoms occur, the disease may have already spread. That’s why it is so important to see your doctor right away if you have these symptoms, so the cause can be found and treated. Continue reading →
In a pathology report, the diagnosis section provides the location of the tumor, its type and grade, and size.
Chances are, the treatment plan for your cancer was determined by the results on a pathology report. Before your diagnosis, you probably had a biopsy or surgery where a doctor removed cells or tissue for study under a microscope. Specialists called pathologists spend their days viewing these samples, understanding how they look compared to normal cells and preparing reports which summarize the findings on each biopsy for oncologists and surgeons.
We spoke with Cancer Center pathologist, Celina Kleer, M.D., director of the Breast Pathology Division in the Department of Pathology,to find out the information contained in a report and how your oncologist uses it to decide the best course of treatment for your cancer. Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.